Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE3
Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKI
- Status
- RECRUITING
- Phase
- PHASE2
SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis
- Status
- RECRUITING
- Phase
- NA
Third-generation EGFR-TKI Plus Anlotinib as Maintenance for NSCLC With Small Cell Transformation After EGFR-TKI Resistance
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 2 Clinical Study of ABSK061 and ABSK043
- Status
- RECRUITING
- Phase
- PHASE2
A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
- Status
- RECRUITING
- Phase
- N/A
A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2